King's College London

Research portal

Improvement in Hepatic Encephalopathy with Rifaximin Is Associated with Distinct Changes in the Metagenomic Species in the Saliva and Stool Microbiome and a Reduction in Systemic Inflammation - Results of the Rifsys Randomized Controlled Trial.

Research output: Contribution to journalMeeting Abstract

Original languageEnglish
Pages (from-to)1462A-1463A
JournalHepatology
Volume68
Issue number6
Publication statusPublished - Dec 2018

King's Authors

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454